Table 1 Patients demographics and Statin indications
Baseline characteristics (N = 675) | Number of patients (%) |
|---|---|
Gender | |
Female Male | 208 (30.8%) 467 (69.2%) |
Ethnicity | |
Arabs | 263 (38.9%) |
Indians | 186 (27.5%) |
East Asians | 128 (19%) |
Europeans | 38 (5.7%) |
Others | 60 (8.8%) |
Statin dose | |
Moderate intensity Rosuvastatin (5-10 mg) Moderate intensity Atorvastatin (10-20 mg) High intensity Rosuvastatin (20-40 mg) High intensity Atorvastatin (40-80 mg) | 186 (27.5%) 180 (26.6%) 137 (20.3%) 172 (25.5%) |
Indication | |
Secondary Prevention (Previous Cardiac event) Diabetes Primary Prevention [Dyslipidaemia defined as LDL > 190 mg/dL (4.92 mmol/L)]. | 187 (27.6%) 270 (40%) 127 (18.8%) |
Primary Prevention [ASCVD > 7.5%] | 91 (53.6%) |
Other diseases | |
Hypertension | 202 (30%) |